J&J | JNJ - Ebit


J&J reported $6.47B in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
AbbVie USD 6.88B 156M Sep/2026
Abbott USD 1.36B 775M Sep/2026
Amgen USD 4.68B 65M Sep/2026
AstraZeneca USD 4.66B 1.5B Sep/2026
Baxter International USD 314M 38M Sep/2026
Bayer EUR 129M 626M Sep/2026
Becton, Dickinson and Co. USD 1.11B 357M Sep/2026
Biogen USD 419.5M 663.3M Sep/2026
Boston Scientific USD 1.01B 232M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
CONMED USD 37.14M 739K Sep/2026
Cooper Companies USD 222M 253M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 542.7M 23.2M Sep/2026
Eli Lilly USD 13.09B 635M Sep/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
Globus Medical USD 178.23M 224.2M Sep/2026
Insulet USD 189.8M 60.1M Sep/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
J&J USD 6.47B 1B Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Merck USD 7.33B 6.49B Sep/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Novartis USD 5.14B 411M Sep/2026
Pfizer USD 4.85B 5.03B Sep/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 4.72B 3.6B Sep/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -2.37M 11.42M Sep/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026
Vertex Pharmaceuticals USD 1.26B 11.3M Sep/2026
Zimmer Biomet Holdings USD 341.5M 3.2M Sep/2026
Zoetis USD 1.03B 88M Sep/2026